Pacific Biosciences Up Over 30%, On Pace for Largest Percent Increase Since July 2024 -- Data Talk

Pacific Biosciences of California, Inc. (PACB) is currently at $2.39, up $0.56 or 30.6%

--Would be highest close since Jan. 27, 2026, when it closed at $2.57

--On pace for largest percent increase since July 16, 2024, when it rose 34.26%

--Currently up six of the past seven days

--Currently up five consecutive days; up 69.5% over this period

--Longest winning streak since June 1, 2026, when it rose for five straight trading days

--Best five day stretch since the five days ending Nov. 8, 2018, when it rose 72.95%

--Up 76.38% month-to-date

--Up 27.81% year-to-date

--Down 95.33% from its all-time closing high of $51.15 on Feb. 11, 2021

--Up 73.19% from 52 weeks ago (Oct. 1, 2025), when it closed at $1.38

--Down 10.49% from its 52-week closing high of $2.67 on Jan. 22, 2026

--Up 115.32% from its 52-week closing low of $1.11 on Aug. 12, 2026

--Traded as high as $2.46; highest intraday level since Jan. 28, 2026, when it hit $2.60

--Up 34.15% at today's intraday high; largest intraday percent increase since Feb. 14, 2025, when it rose as much as 39.19%

All data as of 2:30:36 PM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 30, 2026 14:32 ET (18:32 GMT)